Remarkably, IL-9 enhanced the ability of macrophages to induce tumor migration of both B16 tumor cells and LLC tumor cells (Fig. 5g–i), while IL-9 treatment on Il9r−/− macrophages had no effect (Supplementary Fig. 3f). Here, IL9R is linked to neoplasm.